National Healthcare Properties, Inc. (NHPAP) Form 8-K — Aug 5, 2026
National Healthcare Properties entered into an amended and restated $1.2 billion unsecured credit agreement with Wells Fargo Bank as administrative agent on August 3, 2026, more than doubling total commitments from $550 million via a $750 million revolver, a $300 million term loan, and a new $150 million delayed draw term loan, with tighter SOFR spreads; it also repaid $332 million of Fannie Mae secured debt in connection with the recast. Second quarter 2026 results showed a net loss attributable to common stockholders of $(0.13) per share, Nareit FFO of $0.19 per diluted share, and SHOP same store cash NOI growth of 20.1% year-over-year.
Key figures
- Revenue
- 87530000
- Guidance
- FY2026 SHOP Same Store Cash NOI growth raised to 15.0%-18.0% (from 13.0%-16.0%); dispositions raised to $570 million (from $528 million); acquisitions unchanged at $375-$425 million; G&A $27-$28 million; equity-based compensation $6-$7 million
- Total Debt
- approximately $0.8 billion
- Debt Amount
- 1200000000
- Total Assets
- 1976269000
- Cash Position
- 245695000
- Interest Rate
- SOFR + 1.05%-1.55% (revolving) and 1.10%-1.80% (term) pre-investment-grade election; facility fee 0.15%-0.35%; weighted average economic rate on existing debt 5.69%
- Maturity Date
- Revolving Facility: August 3, 2030; Term Loan and Delayed Draw Term Loan: August 3, 2029
- Net leverage
- 4.9x as of June 30, 2026 vs 9.2x as of June 30, 2025
- Ffo per share
- 0.19
- Preferred tender
- $28.1 million liquidation preference at 8.1% weighted average yield, $2.0 million annual dividend savings
- Revolver capacity
- $750 million (up from $400 million)
- Accordion capacity
- $1.0 billion (up from $450 million)
- Ipo gross proceeds
- $531.3 million (44.3 million Class A shares, April 2026)
- Term loan capacity
- $300 million (up from $150 million)
- Delayed draw term loan
- $150 million (new)
- Fannie mae debt repaid
- $332 million
- Normalized ffo per share
- 0.18
- Omf same store occupancy
- 94.3%
- Normalized ffo yoy change
- -18.2%
- Quarterly common dividend
- $0.075 per share
- Shop same store occupancy
- 84.1% (+1.4% YoY)
- Series a preferred redemption
- 3,289,061 shares at $25.32 per share, redemption date September 4, 2026
- Series b preferred redemption
- 2,850,427 shares at $25.47 per share, redemption date October 6, 2026
- Omf same store cash noi growth
- -0.4%
- Net loss attributable to common
- -$8.14 million
- Shop same store cash noi growth
- 20.1%
- Shop same store cash noi margin
- 22.4% (+2.3% YoY)
- Total portfolio same store cash noi growth
- 6.8%
Price after filing
Close on the filing date to close N calendar days later (from $15.57). Historical, not a forecast.
AI analysis
The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.
AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.